First do no harm: Moving beyond universal pre-procedural testing for COVID-19
Abstract Pre-procedural testing for SARS-CoV-2 was introduced early in the pandemic in an effort to protect healthcare workers, direct appropriate use of personal protective equipment (PPE), and improve patient outcomes. In light of our appreciation for the efficacy of PPE and the nuances associated with interpretation of polymerase chain reaction (PCR) testing for SARS-CoV-2, particularly as community transmission decreases, we call for a re-evaluation of universal pre-procedural testing. We propose a transition to a patient-centered approach, focusing on testing patients whose outcomes would be improved by a delayed procedure in the event of a positive test and a greater reliance on appropriate PPE rather than pre-procedural test results. We recommend that a community infection rate threshold be set at which point pre-procedural testing is discontinued, understanding that there is an inflection point at which testing downsides outweigh the benefits.